87629-39-8 Usage
Salt Form
Monomethanesulfonate
The salt form of the parent compound 1-ethyl-3-(4-fluorophenyl)-4,5,6,7-tetrahydro-5-methyl-1H-pyrazolo[4,3-c]pyridine.
Parent Compound
1-ethyl-3-(4-fluorophenyl)-4,5,6,7-tetrahydro-5-methyl-1H-pyrazolo[4,3-c]pyridine
A potential inhibitor of protein kinase D in cancer therapy.
Potential Applications
Antineoplastic and antitumor agent
Capable of inhibiting the growth and proliferation of cancer cells.
Additional Properties
Anti-inflammatory and analgesic
Being studied for its potential to reduce inflammation and relieve pain.
Structure and Properties
Promising candidate for pharmaceutical research
The compound's structure and properties make it a valuable subject for further research and development in the pharmaceutical industry.
Check Digit Verification of cas no
The CAS Registry Mumber 87629-39-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,7,6,2 and 9 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 87629-39:
(7*8)+(6*7)+(5*6)+(4*2)+(3*9)+(2*3)+(1*9)=178
178 % 10 = 8
So 87629-39-8 is a valid CAS Registry Number.
87629-39-8Relevant academic research and scientific papers
Synthesis, in Vitro 3H>Prazosin Displacement, and in Vivo Activity of 3-Aryl-4,5,6,7-tetrahydropyrazolopyridines, a New Class of Antihypertensive Agents
Winters, Giorgio,Sala, Alberto,Barone, Domenico,Baldoli, Emiliana
, p. 934 - 940 (2007/10/02)
A series of a new 3-aryl-4,5,6,7-tetrahydropyrazolopyridines was synthesized and screened for in vitro 3H>prazosin displacement activity.The results correlated well with their antihypertensive activity in spontaneous hypertensive rats.
